Figure 1From: BI-HEX®-GlymaxX® cells enable efficient production of next generation biomolecules with enhanced ADCC activityA) Comparison of ADCC activity of Rituximab produced in either BI-HEX® or BI-HEX®-GlymaxX® . B) ADCC activity of 3 different mAbs produced in BI-HEX®-GlymaxX® . Three independent production runs were performed for each mAb. The mAbs were individually purified by protein A capture before ADCC activity determination.Back to article page